Lumeria logo

Lumeria

Summer 2026Active

Oura Ring for Skin

Lumeria (S26) at a glance

  1. A product built around repeated use. Lumeria gives people a way to record changes over time.
  2. Two reasons to pay. A preorder measures interest in the device. App renewals would show whether users keep paying for the record and its analysis.
  3. Delivery is still the test. The public schedule describes expected shipping. It does not establish shipments or retention.

Overview

Lumeria is a consumer startup developing a phone attachment and app for keeping track of changes in a person’s skin. Maryanne Alhallak and Anthea Guo founded it and joined Y Combinator’s Summer 2026 batch. The device is called the Lumoscope. Unlike a snapshot taken during an appointment or while shopping, the company’s proposed product gives the user a record they can return to and compare with later scans. [1] [2] [3]

The startup is selling that idea in two parts. It takes preorders for the device and offers a Premium tier in the app. The case for the subscription depends on a customer continuing to use that record after the first scan. The preorder terms give the company a way to learn about willingness to pay while it still needs to deliver physical devices. [4] [5]

A way to follow change between appointments

In interviews published by UC Berkeley, Guo and Alhallak described coming to the idea from different experiences. Guo wanted a record of changes people could refer back to when trying to understand what was happening to their skin. Alhallak had watched a dermatologist make decisions with the information available at an appointment and wondered what patients could record at home. Berkeley’s July report described a device still in development. The founders’ own site identifies Alhallak as CEO and Guo as CTO. [2] [3]

The product’s business premise is a repeated routine. A buyer would have to make time to capture later scans and see enough value in the comparison to continue. That helps explain why the device and app are sold together. The attachment supplies the images and the app gives people a place to keep and revisit the record. These are descriptions of the intended use. They do not establish clinical accuracy or a health outcome. [1] [2]

Charging for a device and a subscription

Lumeria’s October terms say the customer pays when placing a preorder. The company limits shipment to United States addresses and allows customers to request a refund before shipping. Early orders kept an earlier expected shipping window, while newer orders were expected to ship in January 2027. Those dates are estimates from the company. They do not establish that any particular batch shipped or that customers kept their devices. [4]

The terms give device buyers an introductory Premium period and describe an optional prepaid year. Lumeria also reported adding monthly and yearly billing choices in the app. A hardware order is evidence of willingness to try the product. A renewal would show that someone kept paying after trying it. The reviewed sources do not disclose completed shipments, reorder activity or how often device buyers stay subscribed. [4] [5]

That makes Lumeria’s first commercial test relatively concrete. The team needs to fulfill early orders and see whether buyers find a useful reason to scan again. The founder interviews help explain why someone might want a record. The preorder and billing pages show how the company asks users to pay for one. The size and durability of that market remain open. [2] [4] [5]

Timeline

  • Summer 2026 — Lumeria joined Y Combinator and UC Berkeley profiled the founders and the device they were developing. [1] [2]
  • October 2026 — Lumeria published revised preorder terms for the Lumoscope. [4]
  • November 2026 — The company reported showing monthly or yearly Premium billing choices in the app. [5]

Sources

  1. Y Combinator’s Lumeria profile
  2. UC Berkeley’s interview with the founders
  3. Lumeria’s founder page
  4. Lumeria’s October preorder terms
  5. Lumeria’s November product changelog

Pressure-test this opportunity

Explore the risks and possibilities with a prompt for ChatGPT, Claude, or your agent.